文献速递儿科影像技术与安全MR

MRI影像组学在预测神经母细胞瘤MYCN扩增中的作用

Role of MRI radiomics for the prediction of MYCN amplification in neuroblastomas.
PubMed 文献 · Eur Radiol · 2023-05-13

本研究评估MRI影像组学并开发机器学习分类器预测神经母细胞瘤MYCN扩增。120例患者中74例在本机构成像用于开发模型,46例外院成像用于测试。支持向量机分类器在测试集AUC为0.78,敏感度64%,特异度72%。结论提供初步回顾性证据表明MRI影像组学预测MYCN扩增可行。

要点

  • MRI影像组学机器学习模型可预测神经母细胞瘤MYCN扩增,支持向量机测试集AUC 0.78。
  • 支持向量机分类器在外部测试集敏感度64%、特异度72%。
  • 逻辑回归与随机森林模型AUC均为0.75。

核心结论

  • 研究提供初步回顾性证据,表明MRI影像组学预测神经母细胞瘤MYCN扩增具有可行性;未来需研究其他影像特征与遗传标志物的相关性并开发多分类预测模型。

研究设计与样本

  • 回顾性研究,共120例神经母细胞瘤患者,其中74例(平均年龄6岁2个月±4年9个月;43女31男,14例MYCN扩增)在本机构成像用于开发影像组学模型;46例(平均年龄5岁11个月±3年9个月;26女14男,14例MYCN扩增)在外院成像作为外部测试集。采用全肿瘤感兴趣体积提取一阶直方图和二阶影像组学特征,使用组内相关系数和最大相关最小冗余算法筛选特征,以逻辑回归、支持向量机和随机森林作为分类器。

诊断标准与关键数值

  • 外部测试集上,支持向量机分类器AUC为0.78,敏感度64%,特异度72%;逻辑回归模型和随机森林模型AUC均为0.75。

临床应用与阅片要点

  • 作者认为,治疗前MR影像的影像组学分析可用于预测神经母细胞瘤MYCN扩增;影像组学机器学习模型对外部测试集显示出良好的泛化性,表明计算模型具有可重复性。

局限性

  • 研究为初步回顾性证据。
  • 未来需开展研究探索其他影像特征与遗传标志物之间的相关性。
  • 未来需开发多分类预测模型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We evaluate MR radiomics and develop machine learning-based classifiers to predict MYCN amplification in neuroblastomas.

METHODS: A total of 120 patients with neuroblastomas and baseline MR imaging examination available were identified of whom 74 (mean age ± standard deviation [SD] of 6 years and 2 months ± 4 years and 9 months; 43 females and 31 males, 14 MYCN amplified) underwent imaging at our institution. This was therefore used to develop radiomics models. The model was tested in a cohort of children with the same diagnosis but imaged elsewhere (n = 46, mean age ± SD: 5 years 11 months ± 3 years 9 months, 26 females and 14 MYCN amplified). Whole tumour volumes of interest were adopted to extract first-order histogram and second-order radiomics features. Interclass correlation coefficient and maximum relevance and minimum redundancy algorithm were applied for feature selection. Logistic regression, support vector machine, and random forest were employed as the classifiers. Receiver operating characteristic (ROC) analysis was performed to evaluate the diagnostic accuracy of the classifiers on the external test set.

RESULTS: The logistic regression model and the random forest both showed an AUC of 0.75. The support vector machine classifier obtained an AUC of 0.78 on the test set with a sensitivity of 64% and a specificity of 72%.

CONCLUSION: The study provides preliminary retrospective evidence demonstrating the feasibility of MRI radiomics in predicting MYCN amplification in neuroblastomas. Future studies are needed to explore the correlation between other imaging features and genetic markers and to develop multiclass predictive models.

KEY POINTS: • MYCN amplification in neuroblastomas is an important determinant of disease prognosis. • Radiomics analysis of pre-treatment MR examinations can be used to predict MYCN amplification in neuroblastomas. • Radiomics machine learning models showed good generalisability to external test set, demonstrating reproducibility of the computational models.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Ghosh, Yekeler, Teixeira, et al. Role of MRI radiomics for the prediction of MYCN amplification in neuroblastomas. Eur Radiol. 2023. PMID: 37178203. doi:10.1007/s00330-023-09628-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。